Cetera Advisors’s DexCom DXCM Stock Holding History

Cetera Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$5.66M	Buy	40,808 +34,923	+593%	+$4.39M	0.04%	413
2023 Q4	$730K	Buy	5,885 +261	+5%	+$26.7K	0.01%	918
2023 Q3	$525K	Sell	5,624 -406	-7%	-$45.8K	0.01%	1036
2023 Q2	$775K	Buy	6,030 +135	+2%	+$16.3K	0.01%	828
2023 Q1	$685K	Sell	5,895 -314	-5%	-$35.1K	0.01%	862
2022 Q4	$703K	Buy	+6,209	New	+$682K	0.01%	812
2021 Q4	–	Sell	-1,484	Closed	-$203K	–	1462
2021 Q3	$203K	Buy	+1,484	New	+$187K	﹤0.01%	1296
2020 Q4	–	Sell	-2,008	Closed	-$207K	–	1042
2020 Q3	$207K	Sell	2,008 -1,172	-37%	-$122K	0.01%	870
2020 Q2	$322K	Buy	+3,180	New	+$284K	0.01%	681
2019 Q2	–	Sell	-14,664	Closed	-$436K	–	983
2019 Q1	$436K	Buy	+14,664	New	+$515K	0.02%	532
2014 Q2	–	Sell	-20,000	Closed	-$207K	–	607
2014 Q1	$207K	Buy	+20,000	New	+$207K	0.03%	489

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Cetera Advisors's DXCM Position: Q1 2024 in Review

Cetera Advisors increased its DexCom (DXCM) stake by 593% in Q1 2024, buying an estimated $4.39M and bringing the position to 40,808 shares worth $5.66M. The position accounts for 0.04% of the portfolio, ranked #413.

Cetera Advisors first reported a position in DXCM in Q1 2014 and has held it in 11 quarters since. 1,034 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

Cetera Advisors held 40,808 shares of DexCom worth $5.66M as of Q1 2024.
Cetera Advisors bought 34,923 DexCom shares in Q1 2024, an estimated $4.39M.
DexCom made up 0.04% of Cetera Advisors's portfolio in Q1 2024, its #413 holding.
Cetera Advisors first reported a position in DexCom in Q1 2014 and has held it in 11 quarters since.
1,034 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.